(Q27007770)

Rajbala Thakur

series ordinal

2

1 reference

David Nathan Korones

series ordinal

3

1 reference

language of work or name

1 reference

October 2013

1 reference

1 reference

14

1 reference

PubMed

issue

10

1 reference

PubMed

page(s)

1505-17

1 reference

23. Pain in patients with cancer

PubMed

cites work

1 reference

Ketamine: an update on the first twenty-five years of clinical experience

21 January 2018

1 reference

Antagonism of stimulation-produced analgesia by naloxone and N-methyl-D-aspartate: role of opioid and N-methyl-D-aspartate receptors

21 January 2018

1 reference

Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.

21 January 2018

1 reference

Potentiation of μ-opioid receptor-mediated signaling by ketamine

21 January 2018

1 reference

Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review

21 January 2018

1 reference

Ketamine for chronic non-cancer pain

21 January 2018

1 reference

A translational study of the effects of ketamine and pregabalin on temporal summation of experimental pain.

21 January 2018

1 reference

Central sensitization: a generator of pain hypersensitivity by central neural plasticity

21 January 2018

1 reference

Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones

21 January 2018

1 reference

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

21 January 2018

1 reference

Central sensitization: implications for the diagnosis and treatment of pain

21 January 2018

1 reference

Use of oral ketamine in chronic pain management: a review.

21 January 2018

1 reference

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

Ketamine as an adjuvant to opioids for cancer pain

21 January 2018

1 reference

Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain

21 January 2018

1 reference

Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.

21 January 2018

1 reference

Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy.

21 January 2018

1 reference

Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.

21 January 2018

1 reference

"Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients

21 January 2018

1 reference

Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients

21 January 2018

1 reference

Successful use of ketamine for intractable cancer pain

21 January 2018

1 reference

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.

21 January 2018

1 reference

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study

21 January 2018

1 reference

Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.

21 January 2018

1 reference

Use of continuous intravenous ketamine for end-stage cancer pain in children

21 January 2018

1 reference

Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma

21 January 2018

1 reference

Oral ketamine for pain relief in a child with abdominal malignancy

21 January 2018

1 reference

Pharmacokinetics and analgesic effects of i.m. and oral ketamine

21 January 2018

1 reference

Oral ketamine therapy in the treatment of postamputation stump pain

21 January 2018

1 reference

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.

21 January 2018

1 reference

Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1.

21 January 2018

1 reference

Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain

21 January 2018

1 reference

Ketamine mouthwash for mucositis pain

21 January 2018

1 reference

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain

21 January 2018

1 reference

The role of ketamine in pain management.

21 January 2018

1 reference

Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases

21 January 2018

1 reference

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression

21 January 2018

1 reference

A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department

21 January 2018

1 reference

Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency

21 January 2018

1 reference

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

Neuropathological findings after continuous intrathecal administration of S(+)-ketamine for the management of neuropathic cancer pain

21 January 2018

1 reference

Subpial vacuolar myelopathy after intrathecal ketamine: report of a case

21 January 2018

1 reference

Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells.

21 January 2018

1 reference

Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor

21 January 2018

1 reference

Recent developments in the pharmacological management of pain in children

21 January 2018

1 reference

Oral ketamine for children with chronic pain: a pilot phase 1 study

21 January 2018

1 reference

Serious adverse events during procedural sedation with ketamine

21 January 2018

1 reference

Prolonged sedation and airway complications after administration of an inadvertent ketamine overdose in emergency department

21 January 2018

1 reference

Ketamine-associated ulcerative cystitis: a new clinical entity.

21 January 2018

1 reference

Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine

21 January 2018

1 reference

Early exposure to anesthesia and learning disabilities in a population-based birth cohort

21 January 2018

1 reference

Ketamine as an adjuvant to opioids for cancer pain

21 January 2018

1 reference

Ketamine and chronic pain--going the distance

21 January 2018

1 reference

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine

21 January 2018

1 reference

Increased response to ketamine following treatment at long intervals: implications for intermittent use.

21 January 2018

1 reference

In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users

21 January 2018

1 reference

Cognitive impairment among methadone maintenance patients

21 January 2018

1 reference

A strategy for conversion from subcutaneous to oral ketamine in cancer pain patients: effect of a 1:1 ratio

21 January 2018

1 reference